Evidence map›Paper›PMID 31701185›Full record

ArticleRheumatology international2020

Periodontal disease and influence of periodontal treatment on disease activity in patients with rheumatoid arthritis and spondyloarthritis.

Katarzyna Białowąs, Małgorzata Radwan-Oczko, Irena Duś-Ilnicka, Lucyna Korman, Jerzy Świerkot

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 5 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 5 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Oral Microbiome Dysbiosis and Citrullination in Rheumatoid Arthritis.Advances in experimental medicine and biology · 2025
    Review
  8. Review
  9. Neutrophils in Inflammatory Bone Diseases.Current osteoporosis reports · 2024
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Katarzyna BiałowąsDepartment of Rheumatology and Internal Medicine, Wroclaw Medical University, Ulica Borowska 213, 50-556, Wroclaw, Poland. katarzyna.bialowas@interia.pl.ORCID http://orcid.org/0000-0003-4355-0611
Małgorzata Radwan-OczkoDepartment of Oral Pathology, Wroclaw Medical University, Ulica Krakowska 26, 50-425, Wroclaw, Poland.
Irena Duś-IlnickaDepartment of Oral Pathology, Wroclaw Medical University, Ulica Krakowska 26, 50-425, Wroclaw, Poland.
Lucyna KormanDepartment of Rheumatology and Internal Medicine, Wroclaw Medical University, Ulica Borowska 213, 50-556, Wroclaw, Poland.
Jerzy ŚwierkotDepartment of Rheumatology and Internal Medicine, Wroclaw Medical University, Ulica Borowska 213, 50-556, Wroclaw, Poland.
Wroclaw Medical University · PL

Funding

Wroclaw Medical University Pbmn 151
6 · The paper itself

Abstract

The aim of this study was to assess the prevalence of periodontal disease and the effect of periodontal treatment in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA). Forty-four RA patients, thirty SpA patients and thirty-nine healthy volunteers were recruited to the study. Periodontal examination included the approximal plaque index (API), bleeding on probing (BoP), probing depth (PD) and number of teeth. Samples from the deepest periodontal pockets were taken for the detection of Porphyromonas gingivalis DNA with the use of the polymerase chain reaction. All subjects with periodontitis, who completed the study, received periodontal treatment consisting of scaling/root planing and oral hygiene instructions. Disease activity scores, clinical and laboratory parameters were assessed before and 4-6 weeks after periodontal treatment. No significant difference in the prevalence of periodontal disease and the presence of P. gingivalis DNA were found in RA and SpA patients compared to healthy controls. Significantly higher API (80% vs 63%; p = 0.01) and a lower number of teeth (20 vs 25, p = 0.001) were found in RA patients. BoP was significantly elevated in SpA patients (51% vs 33%, p = 0.02). Disease activity measured by the DAS28(CRP) was significantly reduced in RA patients after periodontal treatment (p = 0.002). Clinical and biochemical parameters were not improved in SpA patients. Nonsurgical periodontal treatment had an impact on the decrease in RA activity. Periodontal examination is necessary in patients with RA to detect and treat periodontitis at an early stage.

Indexed as

Root PlaningAdultAgedAged, 80 and overArthritis, RheumatoidComorbidityFemaleHumansMaleMiddle AgedPeriodontal DiseasesPorphyromonas gingivalisPrevalenceSeverity of Illness IndexSpondylarthritisTreatment OutcomePeriodontal treatmentPeriodontitisPorphyromonas gingivalisRheumatoid arthritisSpondyloarthritis

Identifiers

PMID31701185
OpenAlexW2985899718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.